Vanguard Group’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
1,454,038
+168,265
| +13% | +$278K | ﹤0.01% | 3479 |
|
|
2025
Q1 | $1.71M | Buy |
1,285,773
+13,433
| +1% | +$17.9K | ﹤0.01% | 3543 |
|
|
2024
Q4 | $2.38M | Buy |
1,272,340
+72,692
| +6% | +$136K | ﹤0.01% | 3511 |
|
|
2024
Q3 | $931K | Sell |
1,199,648
-14,973
| -1% | -$11.6K | ﹤0.01% | 3795 |
|
|
2024
Q2 | $911K | Buy |
1,214,621
+83,091
| +7% | +$62.3K | ﹤0.01% | 3816 |
|
|
2024
Q1 | $1.2M | Buy |
1,131,530
+159,729
| +16% | +$169K | ﹤0.01% | 3750 |
|
|
2023
Q4 | $1.02M | Buy |
971,801
+21,810
| +2% | +$22.9K | ﹤0.01% | 3822 |
|
|
2023
Q3 | $1.06M | Buy |
949,991
+56,700
| +6% | +$63.5K | ﹤0.01% | 3808 |
|
|
2023
Q2 | $1.34M | Hold |
893,291
| – | – | ﹤0.01% | 3804 |
|
|
2023
Q1 | $1.39M | Buy |
893,291
+39,900
| +5% | +$62.2K | ﹤0.01% | 3806 |
|
|
2022
Q4 | $544K | Sell |
853,391
-18,615
| -2% | -$11.9K | ﹤0.01% | 4074 |
|
|
2022
Q3 | $1.16M | Buy |
872,006
+84,018
| +11% | +$112K | ﹤0.01% | 3955 |
|
|
2022
Q2 | $1.75M | Sell |
787,988
-339,488
| -30% | -$754K | ﹤0.01% | 3861 |
|
|
2022
Q1 | $6.98M | Buy |
1,127,476
+50,506
| +5% | +$313K | ﹤0.01% | 3349 |
|
|
2021
Q4 | $13.6M | Buy |
1,076,970
+64,047
| +6% | +$808K | ﹤0.01% | 3059 |
|
|
2021
Q3 | $92.8M | Buy |
1,012,923
+96,587
| +11% | +$8.85M | ﹤0.01% | 2013 |
|
|
2021
Q2 | $48.6M | Buy |
916,336
+59,471
| +7% | +$3.15M | ﹤0.01% | 2390 |
|
|
2021
Q1 | $30.9M | Buy |
856,865
+139,044
| +19% | +$5.01M | ﹤0.01% | 2576 |
|
|
2020
Q4 | $19.9M | Buy |
717,821
+19,445
| +3% | +$540K | ﹤0.01% | 2631 |
|
|
2020
Q3 | $34.9M | Buy |
698,376
+98,578
| +16% | +$4.93M | ﹤0.01% | 2198 |
|
|
2020
Q2 | $27.8M | Buy |
599,798
+150,554
| +34% | +$6.97M | ﹤0.01% | 2272 |
|
|
2020
Q1 | $20.5M | Buy |
449,244
+37,589
| +9% | +$1.71M | ﹤0.01% | 2273 |
|
|
2019
Q4 | $23.1M | Buy |
411,655
+178,297
| +76% | +$10M | ﹤0.01% | 2462 |
|
|
2019
Q3 | $5.82M | Buy |
233,358
+58,620
| +34% | +$1.46M | ﹤0.01% | 3083 |
|
|
2019
Q2 | $7.43M | Buy |
+174,738
| New | +$7.43M | ﹤0.01% | 3023 |
|